TIM‐4 increases the proportion of CD4+CD25+FOXP3+ regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting IL‐6 secretion. The gene discussed is CD4; the disease is pancreatic ductal adenocarcinoma.